tiprankstipranks
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Income Statement

Compare
539 Followers

Brainstorm Cell Therapeutics Income Statement

Last quarter (Q3 2024), Brainstorm Cell Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Brainstorm Cell Therapeutics's net income was $-2.71M. See Brainstorm Cell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ -366.00K
Gross Profit
$ -265.00K$ -285.00K$ -260.00K$ -219.00K$ -732.00K
Operating Expenses
$ 21.17M$ 24.82M$ 24.54M$ 31.68M$ 23.00M
Depreciation and Amortization
$ 265.00K$ 285.00K$ 260.00K$ 219.00K$ 164.00K
EBITDA
$ -16.93M$ -23.99M$ -24.28M$ -31.46M$ -23.09M
Operating Income
$ -21.44M$ -24.82M$ -24.54M$ -31.68M$ -23.00M
Other Income/Expenses
$ 4.25M$ 545.00K$ 82.00K$ -127.00K$ -252.00K
Pretax Income
$ -17.19M$ -24.28M$ -24.46M$ -31.81M$ -23.25M
Net Income
$ -17.19M$ -23.73M$ -24.38M$ -31.94M$ -23.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.40$ -0.65$ -0.67$ -1.07$ -1.07
Diluted EPS
$ -0.40$ -0.65$ -0.67$ -1.07$ -1.07
Weighted Average Shares Outstanding
42.98M 36.51M 36.18M 29.85M 21.91M
Weighted Average Shares Outstanding (Diluted)
43.08M 36.51M 36.18M 29.85M 21.91M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis